Tisi, Maria Chiara
 Distribuzione geografica
Continente #
NA - Nord America 1.572
EU - Europa 1.476
AS - Asia 854
SA - Sud America 138
AF - Africa 28
OC - Oceania 3
Totale 4.071
Nazione #
US - Stati Uniti d'America 1.542
DE - Germania 600
SG - Singapore 352
CN - Cina 312
PL - Polonia 163
SE - Svezia 163
IT - Italia 136
BR - Brasile 115
GB - Regno Unito 103
FR - Francia 88
UA - Ucraina 71
IN - India 57
IE - Irlanda 38
VN - Vietnam 36
FI - Finlandia 34
ID - Indonesia 26
RU - Federazione Russa 23
TR - Turchia 22
BE - Belgio 13
CA - Canada 11
MX - Messico 9
CI - Costa d'Avorio 8
LT - Lituania 8
AT - Austria 7
BD - Bangladesh 7
ZA - Sudafrica 7
IR - Iran 6
AR - Argentina 5
EC - Ecuador 5
ES - Italia 5
JP - Giappone 5
NL - Olanda 5
CH - Svizzera 4
CZ - Repubblica Ceca 4
IQ - Iraq 4
PK - Pakistan 4
UZ - Uzbekistan 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
MA - Marocco 3
PE - Perù 3
TN - Tunisia 3
CG - Congo 2
DK - Danimarca 2
EG - Egitto 2
ET - Etiopia 2
IL - Israele 2
JM - Giamaica 2
MY - Malesia 2
PY - Paraguay 2
RO - Romania 2
SA - Arabia Saudita 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GR - Grecia 1
GT - Guatemala 1
HK - Hong Kong 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
LV - Lettonia 1
MD - Moldavia 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
PW - Palau 1
SV - El Salvador 1
Totale 4.071
Città #
Chandler 250
Singapore 185
Warsaw 159
Ashburn 136
Fairfield 80
Beijing 72
Jacksonville 67
Ann Arbor 65
Nanjing 56
New York 54
Nürnberg 48
Woodbridge 48
Dearborn 47
San Mateo 41
Munich 39
Dublin 38
Wilmington 38
Los Angeles 37
Houston 35
Seattle 35
Cattolica 30
Jakarta 26
Frankfurt am Main 24
Chicago 21
Milan 21
Rome 21
Bremen 17
Lancaster 17
Nanchang 17
Hefei 16
Boston 15
Kunming 15
Dallas 14
Helsinki 14
Lawrence 14
London 14
Cambridge 13
Marseille 13
Brussels 12
Moscow 12
Redmond 12
Hanoi 11
Redwood City 11
Fremont 10
Ho Chi Minh City 10
Princeton 10
Hyderabad 9
Tianjin 9
Abidjan 8
Izmir 8
Jiaxing 8
Salt Lake City 8
Buffalo 7
Changsha 7
Hangzhou 7
Norwalk 7
São Paulo 7
Tampa 7
Boardman 6
Guangzhou 6
Santa Clara 6
Shenyang 6
Alghero 5
Atlanta 5
Auburn Hills 5
Belo Horizonte 5
Brooklyn 5
Chengdu 5
Düsseldorf 5
Elk Grove Village 5
Hebei 5
Jinan 5
Johannesburg 5
Poplar 5
Shanghai 5
University Park 5
Zhengzhou 5
Istanbul 4
Kocaeli 4
Leawood 4
Mexico City 4
Montreal 4
Mumbai 4
Phoenix 4
Romainville 4
Roubaix 4
San Jose 4
Turku 4
Wroclaw 4
Amsterdam 3
Andover 3
Augusta 3
Berlin 3
Bexley 3
Giugliano in Campania 3
Kent 3
Lanzhou 3
Manchester 3
Pune 3
Quito 3
Totale 2.212
Nome #
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 401
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 319
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 314
THE PROGNOSTIC ROLE OF EBV IN PERIPHERAL BLOOD OF PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA 271
Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker 260
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma. 215
Anemia in Diffuse Large B cell Non-Hodgkin Lymphoma: The Role of IL-6, Hepcidin and Erythropoietin 201
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 162
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 145
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication 141
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma 140
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication. 138
Intravascular large-B cell lymphoma: when lymphoma is suspected but routine diagnostic work-up is negative. 135
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 127
FDG-PET/CT at the end of immuno-chemotherapy in follicular lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET) 127
Small lymphocytic lymphoma in a patient with Fabry disease 126
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 126
Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin. 124
Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations 115
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 109
Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma 109
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death 88
Infections in patients with lymphoproliferative diseases treated with targeted agents: SEIFEM multicentric retrospective study 87
Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report 76
Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela Study 60
Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 study 5
Totale 4.121
Categoria #
all - tutte 13.999
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.999


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021168 0 0 0 0 0 16 22 3 30 31 50 16
2021/2022283 40 26 5 5 25 5 12 43 14 17 41 50
2022/2023604 72 83 45 120 28 84 28 51 73 5 9 6
2023/2024236 11 81 4 5 9 43 2 28 1 0 27 25
2024/2025479 16 24 46 26 52 11 27 12 57 43 94 71
2025/2026727 184 34 103 113 248 45 0 0 0 0 0 0
Totale 4.121